17th Global Neuroscience Conference October 16-17, 2017 Osaka, Japan

ConferenceseriesLLC invites all the participants from all over the world to attend the Neurology conference entitled 17th International Conference on Neuroscience which is held during October 17-18, 2017 at Osaka Japan. The main theme of our conference is "Harnessing the understanding and advancement of Brain and Nervous System" which covers wide range of critically important sessions. Neurological disorders are diseases of the brain, spine and the nerves that connect them. There is ample evidence that pinpoints neurological disorders as one of the greatest threats to public health. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and stroke as well as less familiar ones such as front temporal dementia. In the present day scenario a large population of mankind are plagued by mental and neurological illnesses, with almost 165 million people or 38 percent of the population suffering each year from a brain disorder. With only about a third of cases receiving the therapy or medication needed, mental illnesses cause a huge economic and social burden, it found the cost burden of these and neurological disorders amounted to about 386 billion euros ($555 billion) a year. An estimated 6.8 million people die every year as a result of neurological disorders. Neurological disorders public health challenges describes and discusses the increasing global public health importance of common neurological disorders such as dementia, epilepsy, headache disorders, multiple sclerosis, neuroinfections, neurological disorders associated with malnutrition, pain associated with neurological disorders, stroke and traumatic brain injuries. National Alliance provided fund of $650 million to fuel the research on mental illness. NARSAD Young Investigator Grant provides $30,000 per year on research in Neural and behavior disorders such as schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses. Brain tumor research receives less than 1% (0.7%) of national cancer research spending in the UK.